Your browser doesn't support javascript.
loading
Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.
de Jonge, Evert; Friederich, Philip W; Vlasuk, George P; Rote, William E; Vroom, Margaretha B; Levi, Marcel; van der Poll, Tom.
Affiliation
  • de Jonge E; Department of Intensive Care, Academic Medical Center, University of Amsterdam, The Netherlands. e.dejonge@amc.uva.nl
Clin Diagn Lab Immunol ; 10(3): 495-7, 2003 May.
Article in En | MEDLINE | ID: mdl-12738659
ABSTRACT
The activation of coagulation has been shown to contribute to proinflammatory responses in animal and in vitro experiments. Here we report that the activation of coagulation in healthy human subjects by the administration of recombinant factor VIIa also elicits a small but significant increase in the concentrations of interleukin 6 (IL-6) and IL-8 in plasma. This increase was absent when the subjects were pretreated with recombinant nematode anticoagulant protein c2, the inhibitor of tissue factor-factor VIIa.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Recombinant Proteins / Factor VII Limits: Humans Language: En Journal: Clin Diagn Lab Immunol Journal subject: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2003 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Recombinant Proteins / Factor VII Limits: Humans Language: En Journal: Clin Diagn Lab Immunol Journal subject: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2003 Document type: Article Affiliation country: Netherlands
...